Recently added articles from Climacteric:
A decade of swings and arrows
Dec 01, 2007; ... After 10 years, Climacteric is now definitely postmenopausal, but this passage of time has been particularly eventful and exciting. As Editors, it has been our privilege to have the opportunity to comment on many menopausal controversies and, in particular, the clinical interpretation of newly ...
Obituary: Christian Lauritzen, 1923-2007
Dec 01, 2007; ... Christian Lauritzen was born in post-World War I Germany at the time of maximum economic depression and inflation. This was also the time when Expressionism and Dadaism emanated in Europe and Allan and Doisy developed their estrogen bioassay. Following Christian's graduation from a classical, ...
Influence of menopause on mood: a systematic review of cohort studies
Dec 01, 2007; ... Key words: MENOPAUSE. MOOD DISORDERS, AFFECT, CLIMACTERIC, DEPRESSION, DEPRESSIVE DISORDER, EMOTIONS ABSTRACT Objective This systematic evidence review evaluates the independent influence of the menopausal transition on mood including depression, anxiety, and other psychological ...
False alarm: postmenopausal hormone therapy and ovarian cancer/Authors' response
Dec 01, 2007; ... S. Shapiro Department of Family Medicine and Public Health, University of Cape Town Medical School, Cape Town, South Africa Key words: POSTMENOPAUSAL HORMONE THERAPY, OVARIAN CANCER ABSTRACT Background In a follow-up study of 948 576 women, based on respective ...
Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation
Dec 01, 2007; ... Key words: PHYTOESTROGENS, ISOFLAVONES, CARDIOVASCULAR, CLINICAL TRIAL ABSTRACT Objectives Equol, a gut bacterial metabolite of the isoflavone daidzein, has been associated with beneficial health effects. Recent studies indicate that women with intestinal capacity to convert ...
The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy
Dec 01, 2007; ... Key words: CYPROTERONE ACETATE, ENDOMETRIUM, ESTROGEN, GESTODENE, NORETHISTERONE, REGIMEN (INTERRUPTED AND CONTINUOUS), SMOKING ABSTRACT Objective To study the influence of smoking on uterine bleeding patterns during continuous and interrupted oral hormone therapy ...
Moderate alcohol consumption contributes to women's well-being through the menopausal transition
Dec 01, 2007; ... Key words: WELL-BEING, ALCOHOL, EXERCISE, LIFESTYLE, SELF-RATED HEALTH, MENOPAUSE ABSTRACT Objectives To examine the association of alcohol consumption with well-being in mid-aged Australian women, taking into account other lifestyle factors. Methods A prospective, ...
Raloxifene, soy phytoestrogens and endothelial function in postmenopausal women
Dec 01, 2007; ... Key words: ENDOTHELIAL FUNCTION, VASODILATION, BRACHIAL ARTERY, RALOXIFENE, SOY, PHYTOESTROGENS, POSTMENOPAUSAL WOMEN ABSTRACT Objective To compare the effects of raloxifene and soy phytoestrogens on endothelial function in healthy, postmenopausal women. Design ...
Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists
Dec 01, 2007; ... Key words: CARDIOLOGY, CARDIOVASCULAR PREVENTION, CARDIOVASCULAR RISK, GYNECOLOGY, HORMONES, HYPERTENSION, MENOPAUSE, METABOLIC SYNDROME ABSTRACT Cardiovascular risk is poorly managed in women, especially during the menopausal transition when susceptibility to cardiovascular ...
Metabolic syndrome in postmenopausal women: higher prevalence in the Northeastern Region of Brazil than in other Latin American countries and the influence of obesity and socioeconomic factors/Author's reply
Oct 01, 2007; ... We read with great interest the recent manuscript, by the Collaborative Group for Research of the Climacteric in Latin America, on the prevalence of metabolic syndrome (METS) and its components in postmenopausal Latin American women1. The authors analyzed the prevalence of METS according to the ...
Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention
Oct 01, 2007; ... ABSTRACT Cardiovascular disease is the leading cause of mortality and morbidity in women after the age of 50 years in most developed countries. Epidemiology, symptoms and progression of cardiovascular disease are different in women than in men. Indeed, women develop cardiovascular ...
Introduction
Oct 01, 2007; ... This special Supplement of Climacteric brings full-length articles on topics that were presented in the 7th Workshop of the International Menopause Society (IMS), held in Budapest, February 2007. The past decade has witnessed extreme ups-and-downs in regard to postmenopausal hormone ...
Effects of hormone treatment on hemostasis variables
Oct 01, 2007; ... ABSTRACT A survey was made of the changes in hemostasis and related inflammatory biomarkers for hormone treatments (HT) of women. Treatments included were oral and non-oral estrogens combined or not with progestogens, raloxifene, tamoxifene, tibolone and ethinylestradiol in oral ...
Recent epidemiological evidence relevant to the clinical management of the menopause
Oct 01, 2007; ... ABSTRACT Background The 2003 Workshop of the International Menopause Society considered the epidemiological evidence collected up to that time on the effects of female hormone therapy (HT). New evidence relevant to the clinical management of the menopause has since been ...
Diet and lifestyle in managing postmenopausal obesity
Oct 01, 2007; ... ABSTRACT The majority of adults are becoming increasingly overweight and one of the subpopulations in which this prevalence is growing most rapidly is postmenopausal women. It is as yet unclear whether the menopausal transition itself leads to weight gain, but it is known that the ...
Postmenopausal hormones and coronary artery disease: potential benefits and risks
Oct 01, 2007; ... ABSTRACT Various secondary prevention trials, including the Women's Health Initiative (WHI0, assessing the effects of hormone therapy (HT) on coronary artery disease (CAD) showed no benefit, and a trend towards early harm. However, in the WHI trial, there was a significant trend for ...
Breast cancer prevention
Oct 01, 2007; ... ABSTRACT We have developed a new approach for breast cancer prevention, capitalizing in the preventive effect of early first full-term pregnancy, hormonally induced differentiation and our ability to identify specific genomic signatures that allow us to predict risk reduction. Early ...
Exercise in the menopause - an update
Oct 01, 2007; ... ABSTRACT One of the most important components of lifestyle relates to physical activity. Sedentary people fare less well than those who exercise regularly. The benefits of exercise can be demonstrated in many organs of the body. The most frequently studied effect of exercise is reduction ...
Hormone therapy and breast cancer risk
Oct 01, 2007; ... ABSTRACT Hormone therapy (HT) is the most efficacious intervention for the relief of climacteric symptoms. Controversies surrounding HT have left many women puzzled and afraid. Gynecologists are faced with long-standing beneficial assumptions challenged by an abundance of robust ...
Menopause and stroke and the effects of hormonal therapy
Oct 01, 2007; ... ABSTRACT The incidence of stroke increases substantially after menopause, and in the United States it is the third leading cause of death. Data exist suggesting that women have worse outcomes for stroke than do men. Trials of aspirin use further suggest that there is a gender difference ...